Once-a-month oral contraceptive could improve patient adherence

December 04, 2019

Researchers have created a new ingestible drug delivery platform that expands in the stomach and could safely deliver a contraceptive over one month when tested in pigs. The technology could one day help women adhere more easily to birth control regimens by providing an alternative to daily oral contraceptive pills. Daily birth control pills are the preferred form of contraception for a large portion of the population, largely because of their ease of use. However, many women face difficulties with adhering to daily pill schedules - a multinational survey published in 2010, after surveying women in the US, UK, France, Germany, Spain, Italy, Brazil, Australia and Russia, revealed that nearly half of women missed at least one dose over three months or reported taking their pill at the wrong time. These irregularities can reduce the effectiveness of oral pills, to the point where the chance of pregnancy in women that use them is still 9% on average each year. To address these challenges, Ameya Kirtane and colleagues developed a drug delivery system that fits within a gelatin capsule and, after being ingested, expands in the stomach, where it can reside for at least three weeks. When loaded with the contraceptive levonorgestrel and administered to pigs, the platform released the drug into the stomach over one month, and the drug remained detectable in serum for up to 29 days. In contrast, levonorgestrel from an oral immediate-release tablet (Levora) could only be detected in the serum of pigs for around two days. Kirtane et al. say that future studies should test the contraceptive efficacy of their dosage form, as well further refine their technology's materials. They add that their platform has several features, such as the opportunity for self-administration, that could help overcome cultural and economic barriers to long-acting contraceptives in low-income countries.

American Association for the Advancement of Science

Related Contraceptive Articles from Brightsurf:

UC research finds low rates of contraceptive use in women with kidney failure
New research from the University of Cincinnati finds that women with kidney failure have low rates of contraceptive use.

Use of emergency contraceptive pills among Scandinavian women
Use of emergency contraceptive pills (ECPs) is common among Scandinavian women, with one-third having used them at least once, according to a study published in Acta Obstetricia et Gynecologica Scandinavica.

Providing contraceptive care in the pediatric emergency department
A new study found that two-thirds of female adolescents ages 16-21 seen in a pediatric Emergency Department (ED) were interested in discussing contraception, despite having a high rate of recent visits to a primary care provider.

Stopping sperm in its tracks: latest progress in the hunt for a male contraceptive
Researchers at the University of Dundee have developed an unrivalled, fully automated robotic screening system which allows them to rapidly test the effect of drugs and other chemicals on human sperm.

Once-a-month oral contraceptive could improve patient adherence
Researchers have created a new ingestible drug delivery platform that expands in the stomach and could safely deliver a contraceptive over one month when tested in pigs.

Fertilization discovery could lead to new male contraceptive, help infertile couples
An unexpected discovery about fertilization reveals new insights into how sperm and egg fuse and could have major implications for couples battling infertility -- and may lead to a future male contraceptive.

Contraceptive drug shows promise for preventing and regressing cervical cancer
A new study in The American Journal of Pathology, published by Elsevier, reports that medroxyprogesterone acetate (MPA), the active ingredient in the common contraceptive injection Depo-Provera, was effective in preventing the development of cervical cancer in mice with precancerous lesions.

Contraceptive jewelry could offer a new family planning approach
Family planning for women might one day be as simple as putting on an earring.

Long-acting contraceptive designed to be self-administered via microneedle patch
A new long-acting contraceptive designed to be self-administered by women may provide a new family planning option, particularly in developing nations where access to healthcare can be limited, a recent study suggests.

First trial of dapivirine ring with both ARV and contraceptive finds no safety concerns
In the first clinical study of a vaginal ring that releases the antiretroviral drug dapivirine as well as a contraceptive hormone, there were no safety concerns and the ring was well-tolerated.

Read More: Contraceptive News and Contraceptive Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.